Latest / The Investor With Joel Palathinkal
James Sore: SuperSeed Ventures
How do you evaluate a cutting-edge medical device, a breakthrough in green tech, and a new e-commerce platform with the same sharp eye? This week, we sit down with James, a Chief Investment Officer and Fund Manager who has evaluated a staggering 180 early and growth-stage companies across nearly every sector imaginable.
James has a rare superpower: the ability to demystify highly complex technical problems and translate them into compelling investment opportunities. He acts as the essential bridge between visionary founders and savvy investors, ensuring everyone is aligned on the path to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.